This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Allen T.M., Cheng W.W., Hare J.I., Laginha K.M.: Pharmacokinetics and Pharmacodynamics of Lipidic Nano-Particles in Cancer. Anticancer Agents Med Chem 2008, 6, 513–523, doi: 10.2174/187152006778699121.AllenT.M., ChengW.W., HareJ.I., LaginhaK.M.:Pharmacokinetics and Pharmacodynamics of Lipidic Nano-Particles in Cancer.2008,6,513–523, doi:10.2174/187152006778699121.Open DOISearch in Google Scholar
Allen T.M., Cullis P.R.: Liposomal drug delivery systems: From concept to clinical applications. Adv Drug Deliv Rev 2013, 65, 36–48, doi: 10.1016/j.addr.2012.09.037.AllenT.M., CullisP.R.:Liposomal drug delivery systems: From concept to clinical applications.2013,65,36–48, doi:10.1016/j.addr.2012.09.037.Open DOISearch in Google Scholar
Anderson R.L., Balasas T., Callaghan J., Coombes R.C., Evans J., Hall J., Kinrade S., Jones D., Jones P., Jones R., Marshall J., Panico M.B., Shaw J.A., Steeg P., Sullivan M., Warwick T., Westwell A.D., Ritchie J.W.A.: A framework for the development of effective anti-metastatic agents. Nat Rev Clin Oncol 2019, 16, 185–204, doi: 10.1038/s41571-018-0134-8.AndersonR.L., BalasasT., CallaghanJ., CoombesR.C., EvansJ., HallJ., KinradeS., JonesD., JonesP., JonesR., MarshallJ., PanicoM.B., ShawJ.A., SteegP., SullivanM., WarwickT., WestwellA.D., RitchieJ.W.A.:A framework for the development of effective anti-metastatic agents.2019,16,185–204, doi:10.1038/s41571-018-0134-8.Open DOISearch in Google Scholar
Augustine R., Alhussain H., Hasan A., Ahmed M.B., Yalcin H.C., Moustafa A.E.: A novel in ovo model to study cancer metastasis using chicken embryos and GFP expressing cancer cells. Bosn J Basic Med Sci 2020, 20, 140–148. doi: 10.17305/bjbms.2019.4372.AugustineR., AlhussainH., HasanA., AhmedM.B., YalcinH.C., MoustafaA.E.:A novel in ovo model to study cancer metastasis using chicken embryos and GFP expressing cancer cells.2020,20,140–148. doi:10.17305/bjbms.2019.4372.Open DOISearch in Google Scholar
Børresen B., Hansen A.E., Kjær A., Andresen T.L., Kristensen A.T.: Liposome-encapsulated chemotherapy: Current evidence for its use in companion animals. Vet Comp Oncol 2018, 16, E1–E15, doi: 10.1111/vco.12342.BørresenB., HansenA.E., KjærA., AndresenT.L., KristensenA.T.:Liposome-encapsulated chemotherapy: Current evidence for its use in companion animals.2018,16,E1–E15, doi:10.1111/vco.12342.Open DOISearch in Google Scholar
Boston S.E., Ehrhart N.P., Dernell W.S., Lafferty M., Withrowet S.J.: Evaluation of survival time in dogs with stage III osteosarcoma that undergo treatment: 90 cases (1985–2004). J Am Vet Med Assoc 2006, 228, 1905–1908, doi: 10.2460/javma.228.12.1905.BostonS.E., EhrhartN.P., DernellW.S., LaffertyM., WithrowetS.J.:Evaluation of survival time in dogs with stage III osteosarcoma that undergo treatment: 90 cases (1985–2004).2006,228,1905–1908, doi:10.2460/javma.228.12.1905.Open DOISearch in Google Scholar
Eom Y.W., Kim M.A., Park S.S., Goo M.J., Kwon H.J., Sohn S., Kim W.-H., Yoon G., Choi K.S.: Two distinct modes of cell death induced by doxorubicin: Apoptosis and cell death through mitotic catastrophe accompanied by senescence-like phenotype. Oncogene 2005, 24, 4765–4777, doi: 10.1038/sj.onc.1208627.EomY.W., KimM.A., ParkS.S., GooM.J., KwonH.J., SohnS., KimW.-H., YoonG., ChoiK.S.:Two distinct modes of cell death induced by doxorubicin: Apoptosis and cell death through mitotic catastrophe accompanied by senescence-like phenotype.2005,24,4765–4777, doi:10.1038/sj.onc.1208627.Open DOISearch in Google Scholar
European Medicines Agency: EMA/635791/2019/EMEA/H/C/000089 Caelyx pegylated liposomal European public assessment report (EPAR) – Medicine overview. EMA, Amsterdam, 2019, https://www.ema.europa.eu/en/documents/product-information/caelyx-pegylated-liposomal-epar-product-information_en.pdfEuropean Medicines Agency:.EMA,Amsterdam,2019,https://www.ema.europa.eu/en/documents/product-information/caelyx-pegylated-liposomal-epar-product-information_en.pdfSearch in Google Scholar
Haghiralsadat F., Amoabediny G., Sheikhha M.H., Forouzanfar T., Helder M.N., Zandieh-Doulabi B.: A novel approach on drug delivery: Investigation of a new nano-formulation of liposomal doxorubicin and biological evaluation of entrapped doxorubicin on various osteosarcoma cell lines. Cell J 2017, 19, 55–64, doi: 10.22074/cellj.2017.4502.HaghiralsadatF., AmoabedinyG., SheikhhaM.H., ForouzanfarT., HelderM.N., Zandieh-DoulabiB.:A novel approach on drug delivery: Investigation of a new nano-formulation of liposomal doxorubicin and biological evaluation of entrapped doxorubicin on various osteosarcoma cell lines.2017,19,55–64, doi:10.22074/cellj.2017.4502.Open DOISearch in Google Scholar
Janssen L.M.E., Ramsay E.E., Logsdon C.D., Overwijk W.W.: The immune system in cancer metastasis: Friend or foe? J Immunother Cancer 2017, 5, 1–14, doi: 10.1186/s40425-017-0283-9.JanssenL.M.E., RamsayE.E., LogsdonC.D., OverwijkW.W.:The immune system in cancer metastasis: Friend or foe?2017,5,1–14, doi:10.1186/s40425-017-0283-9.Open DOISearch in Google Scholar
Jonkman J.E.N., Cathcart J.A., Xu F., Bartolini M.E., Amon J.E., Stevens K.M., Colarussoet P.: An introduction to the wound healing assay using live-cell microscopy. Cell Adhes Migr 2014, 8, 440–451. doi: 10.4161/cam.36224.JonkmanJ.E.N., CathcartJ.A., XuF., BartoliniM.E., AmonJ.E., StevensK.M., ColarussoetP.:An introduction to the wound healing assay using live-cell microscopy.2014,8,440–451. doi:10.4161/cam.36224.Open DOISearch in Google Scholar
Khan S., Pathak P., Vasudevan S., Nayak D.: Non-invasive photoacoustic screening of blood vasculature during anti-angiogenesis using CAM assay. OSA Contin 2021, 4, 2821, doi: 10.1364/osac.432084.KhanS., PathakP., VasudevanS., NayakD.:Non-invasive photoacoustic screening of blood vasculature during anti-angiogenesis using CAM assay.2021,4,2821, doi:10.1364/osac.432084.Open DOISearch in Google Scholar
Kim Y., Williams K.C., Gavin C.T., Jardine E., Chambers A.F., Leong H.S.: Quantification of cancer cell extravasation in vivo. Nat Protoc 2016, 11, 937–948, doi: 10.1038/nprot.2016.050.KimY., WilliamsK.C., GavinC.T., JardineE., ChambersA.F., LeongH.S.:Quantification of cancer cell extravasation in vivo.2016,11,937–948, doi:10.1038/nprot.2016.050.Open DOISearch in Google Scholar
Lou N, Wang Y., Sun D., Zhao J., Wang Y., Gao Z.: Isolation of stem-like cells from human MG-63 osteosarcoma cells using limiting dilution in combination with vincristine selection. Indian J Biochem Biophys 2010, 47, 340–347.LouN, WangY., SunD., ZhaoJ., WangY., GaoZ.:Isolation of stem-like cells from human MG-63 osteosarcoma cells using limiting dilution in combination with vincristine selection.2010,47,340–347.Search in Google Scholar
Luzzi K.J., MacDonald I.C., Schmidt E.E., Kerkvliet N., Morris V.L., Chambers A.F., Groom A.C.: Multistep nature of metastatic inefficiency: Dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 1998, 153, 865–873, doi: 10.1016/S0002-9440(10)65628-3.LuzziK.J., MacDonaldI.C., SchmidtE.E., KerkvlietN., MorrisV.L., ChambersA.F., GroomA.C.:Multistep nature of metastatic inefficiency: Dormancy of solitary cells after successful extravasation and limited survival of early micrometastases.1998,153,865–873, doi:10.1016/S0002-9440(10)65628-3.Open DOISearch in Google Scholar
Małek A., Taciak B., Sobczak K., Grzelak A., Wójcik M., Mieczkowski J., Lechowski R., Zabielska-Koczywąs K.A.: Enhanced cytotoxic effect of doxorubicin conjugated to glutathione-stabilized gold nanoparticles in canine osteosarcoma—in vitro studies. Molecules 2021, 26, 3487, doi: 10.3390/molecules26123487.MałekA., TaciakB., SobczakK., GrzelakA., WójcikM., MieczkowskiJ., LechowskiR., Zabielska-KoczywąsK.A.:Enhanced cytotoxic effect of doxorubicin conjugated to glutathione-stabilized gold nanoparticles in canine osteosarcoma—in vitro studies.2021,26,3487, doi:10.3390/molecules26123487.Open DOISearch in Google Scholar
Mohanty A., Uthaman S., Park I.K.: Utilization of polymer-lipid hybrid nanoparticles for targeted anti-cancer therapy. Molecules 2020, 25, 4377, doi: 10.3390/molecules25194377.MohantyA., UthamanS., ParkI.K.:Utilization of polymer-lipid hybrid nanoparticles for targeted anti-cancer therapy.2020,25,4377, doi:10.3390/molecules25194377.Open DOISearch in Google Scholar
Pistritto G., Trisciuoglio D., Ceci C., Garufi A., D’Orazi G.: Apoptosis as anticancer mechanism: Function and dysfunction of its modulators and targeted therapeutic strategies. Aging 2016, 8, 603–619, doi: 10.18632/aging.100934.PistrittoG., TrisciuoglioD., CeciC., GarufiA., D’OraziG.:Apoptosis as anticancer mechanism: Function and dysfunction of its modulators and targeted therapeutic strategies.2016,8,603–619, doi:10.18632/aging.100934.Open DOISearch in Google Scholar
Salzberg M., Thürlimann B., Hasler U., Delmore G.C., von Rohr A.D., Thürlimann A. Ruhstaller T.B., Stopatschinskaja S.E., von Moos R.: Pegylated liposomal doxorubicin (Caelyx®) in metastatic breast cancer: A community-based observation study. Oncology 2008, 72, 147–151, doi: 10.1159/000112731.SalzbergM., ThürlimannB., HaslerU., DelmoreG.C., von RohrA.D., ThürlimannA.RuhstallerT.B., StopatschinskajaS.E., von MoosR.:Pegylated liposomal doxorubicin (Caelyx®) in metastatic breast cancer: A community-based observation study.2008,72,147–151, doi:10.1159/000112731.Open DOISearch in Google Scholar
Selvarajah G.T., Kirpensteijn J.: Prognostic and predictive biomarkers of canine osteosarcoma. Vet J 2010, 18, 528–35, doi: 10.1016/j.tvjl.2010.04.010.SelvarajahG.T., KirpensteijnJ.:Prognostic and predictive biomarkers of canine osteosarcoma.2010,18,528–35, doi:10.1016/j.tvjl.2010.04.010.Open DOISearch in Google Scholar
Skorupski K.A., Uhl J.M., Szivek A., Frazier S.D.A., Rebhun R.B., Rodriguez Jr C.O.: Carboplatin versus alternating carboplatin and doxorubicin for the adjuvant treatment of canine appendicular osteosarcoma: A randomized, phase III trial. Vet Comp Oncol 2016, 14, 81–87, doi: 10.1111/vco.12069.SkorupskiK.A., UhlJ.M., SzivekA., FrazierS.D.A., RebhunR.B., RodriguezC.O.Jr:Carboplatin versus alternating carboplatin and doxorubicin for the adjuvant treatment of canine appendicular osteosarcoma: A randomized, phase III trial.2016,14,81–87, doi:10.1111/vco.12069.Open DOISearch in Google Scholar
Straw R.C., Withrow S.J., Powers B.E.: Management of canine appendicular osteosarcoma. Vet Clin North Am Small Anim Pract 1990, 20, 1141–1161, doi: 10.1016/S0195-5616(90)50089-3.StrawR.C., WithrowS.J., PowersB.E.:Management of canine appendicular osteosarcoma.1990,20,1141–1161, doi:10.1016/S0195-5616(90)50089-3.Open DOISearch in Google Scholar
Szewczyk M., Lechowski R., Zabielska K.: What do we know about canine osteosarcoma treatment? – review. Vet Res Commun 2015, 39, 61–67, doi: 10.1007/s11259-014-9623-0.SzewczykM., LechowskiR., ZabielskaK.:What do we know about canine osteosarcoma treatment? – review.2015,39,61–67, doi:10.1007/s11259-014-9623-0.Open DOISearch in Google Scholar
Taghipour M., Vand A.A., Rezaei A., Karimi G.H.: Application of Artificial Neural Network for Modeling and Prediction of MTT Assay on Human Lung Epithelial Cancer Cell Lines. J Biosens Bioelectron 2015, 6, 2, doi: 10.4172/2155-6210. 1000170.TaghipourM., VandA.A., RezaeiA., KarimiG.H.:Application of Artificial Neural Network for Modeling and Prediction of MTT Assay on Human Lung Epithelial Cancer Cell Lines.2015,6,2, doi:10.4172/2155-6210.1000170.Open DOISearch in Google Scholar
Tat J., Liu M., Wen X.Y.: Zebrafish cancer and metastasis models for in vivo drug discovery. Drug Discov Today Technol 2013, 10, e83–e89, doi: 10.1016/j.ddtec.2012.04.006.TatJ., LiuM., WenX.Y.:Zebrafish cancer and metastasis models for in vivo drug discovery.2013,10,e83–e89, doi:10.1016/j.ddtec.2012.04.006.Open DOISearch in Google Scholar
Teske E., Rutteman G.R., Kirpenstein J., Hirschberger J.: A randomized controlled study into the efficacy and toxicity of pegylated liposome encapsulated doxorubicin as an adjuvant therapy in dogs with splenic haemangiosarcoma. Vet Comp Oncol 2011, 9, 283–289, doi: 10.1111/j.1476-5829.2011. 00266.x.TeskeE., RuttemanG.R., KirpensteinJ., HirschbergerJ.:A randomized controlled study into the efficacy and toxicity of pegylated liposome encapsulated doxorubicin as an adjuvant therapy in dogs with splenic haemangiosarcoma.2011,9,283–289, doi:10.1111/j.1476-5829.2011.00266.x.Open DOISearch in Google Scholar
Vail D.M., Kravis L.D., Cooley A.J., Chun R., MacEwen E.G.: Preclinical trial of doxorubicin entrapped in sterically stabilized liposomes in dogs with spontaneously arising malignant tumors. Cancer Chemother Pharmacol 1997, 39, 410–416, doi: 10.1007/s002800050591.VailD.M., KravisL.D., CooleyA.J., ChunR., MacEwenE.G.:Preclinical trial of doxorubicin entrapped in sterically stabilized liposomes in dogs with spontaneously arising malignant tumors.1997,39,410–416, doi:10.1007/s002800050591.Open DOISearch in Google Scholar
Varankar S.S., Bapat S.A.: Migratory Metrics of Wound Healing: A Quantification Approach for in vitro Scratch Assays. Front Oncol 2018, 8, 1–13, doi: 10.3389/fonc.2018.00633.VarankarS.S., BapatS.A.:Migratory Metrics of Wound Healing: A Quantification Approach for in vitro Scratch Assays.2018,8,1–13, doi:10.3389/fonc.2018.00633.Open DOISearch in Google Scholar
Wang L., Pan T., Wang Y., Yu J., Qu P., Chen Y., Xin H., Wang S., Liu J., Wu Y.: Effect of Nanoparticles of DOX and miR-125b on DNA Damage Repair in Glioma U251 Cells and Underlying Mechanisms. Molecules 2022, 27, 1–15, doi: 10.3390/molecules 27196201.WangL., PanT., WangY., YuJ., QuP., ChenY., XinH., WangS., LiuJ., WuY.:Effect of Nanoparticles of DOX and miR-125b on DNA Damage Repair in Glioma U251 Cells and Underlying Mechanisms.2022,27,1–15, doi:10.3390/molecules27196201.Open DOISearch in Google Scholar
Wilk S.S., Zabielska-Koczywas K.A.: Molecular mechanisms of canine osteosarcoma metastasis. Int J Mol Sci 2021, 22, 3639, doi: 10.3390/ijms22073639.WilkS.S., Zabielska-KoczywasK.A.:Molecular mechanisms of canine osteosarcoma metastasis.2021,22,3639, doi:10.3390/ijms22073639.Open DOISearch in Google Scholar
Wlodkowic D., Akagi J., Dobrucki J., Errington R., Smith P.J., Takeda K., Darzynkiewicz Z. Kinetic viability assays using DRAQ7 probe. Curr Protoc Cytom 2013, 65, 9.41.1–9.41.8, doi: 10.1002/0471142956.cy0941s65.WlodkowicD., AkagiJ., DobruckiJ., ErringtonR., SmithP.J., TakedaK., DarzynkiewiczZ.Kinetic viability assays using DRAQ7 probe.2013,65,9.41.1–9.41.8, doi:10.1002/0471142956.cy0941s65.Open DOISearch in Google Scholar
Zabielska-Koczywąs K., Lechowski R.: The use of liposomes and nanoparticles as drug delivery systems to improve cancer treatment in dogs and cats. Molecules 2017, 22, 2167, doi: 10.3390/molecules22122167.Zabielska-KoczywąsK., LechowskiR.:The use of liposomes and nanoparticles as drug delivery systems to improve cancer treatment in dogs and cats.2017,22,2167, doi:10.3390/molecules22122167.Open DOISearch in Google Scholar
Zhao M., Ding X.-F., Shen J.-Y., Zhang X.-P., Ding X.-W., Xu B.: Use of liposomal doxorubicin for adjuvant chemotherapy of breast cancer in clinical practice. J Zhejiang Univ Sci B 2017, 18, 15–26, doi: 10.1631/jzus.B1600303.ZhaoM., DingX.-F., ShenJ.-Y., ZhangX.-P., DingX.-W., XuB.:Use of liposomal doxorubicin for adjuvant chemotherapy of breast cancer in clinical practice.2017,18,15–26, doi:10.1631/jzus.B1600303.Open DOISearch in Google Scholar